FDA's Proposed Rule for Oversight of Laboratory Developed Te

After an over decade-long discourse amongst interested stakeholders, on October 3, 2023, FDA unveiled its proposed rule and policy to increase oversight over LDTs. If...

Related Keywords

, Clinical Laboratory Improvement Amendments , Public Health Surveillance , Academic Medical Centers Amcs , Veterans Health Administration , Tests Subject , Phaseout Policy , Leukocyte Antigen , Law Enforcement , Public Health , Remain Under Active , Federal Food , Cosmetic Act , Blood Donor Screening , Medical Device User Fee Amendments , Unique Device Identification , Investigational Device Exemption , Small Business Determination , Devices Program , Safer Technologies Program , Medical Centers , Validation Programs , New York State Department , Health Clinical Laboratory Evaluation Program , Veterans Health , Q Submission Program , Small Business Certification , Consolidated Appropriations Act , Sunshine Act ,